SNZZF
Senzime AB$0.2850 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.2850, and at the day’s high of $0.2850
- YTD change
- -28.75%
- vs 20-day SMA
- N/A
- vs 200-day SMA
- N/A
Price ranges
Price & Performance
-0.22 (-43.23%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 89.5% away from all-time highs of $2.7200
- SNZZF is down 29% since the beginning of the year
- SNZZF is down 29% over the past 12 months
- SNZZF is down 29% over the past 1 month
SNZZF reads n/a: the 12-month move is -56.2%.
- Previous minute
- +$0.0000
- Last hour
- +$0.0000
- Last 5 days
- -8.06%
- vs 8-day SMA
- -4.22%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Senzime AB engages in the development of enzyme-based biosensor technology for medical and biochemical processes and industries. It manufactures products for automated and continuous monitoring of life-critical substances such as glucose and lactate in both blood and tissues, as well as systems to monitor patient's neuromuscular function perioperatively and in the intensive care medicine setting. The company also distributes bioreactor systems for the pharmaceutical industry. Senzime was founded by Thomas Ambjorn Carlsson in 1999 and is headquartered in Uppsala, Sweden.
Competitor comparison
No peer group available for this symbol.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
